Bin Zheng

Bin Zheng

Harvard University

H-index: 35

North America-United States

About Bin Zheng

Bin Zheng, With an exceptional h-index of 35 and a recent h-index of 26 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Melanoma, MDSC, Immunometabolism, Cancer cell Metabolism, 3D genome organization.

His recent articles reflect a diverse array of research interests and contributions to the field:

Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib

Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

Phenformin promotes keratinocyte differentiation via the calcineurin/NFAT pathway

Bin Zheng Information

University

Position

Massachusetts General Hospital, Harvard Medical School

Citations(all)

8164

Citations(since 2020)

3465

Cited By

6070

hIndex(all)

35

hIndex(since 2020)

26

i10Index(all)

43

i10Index(since 2020)

39

Email

University Profile Page

Google Scholar

Bin Zheng Skills & Research Interests

Melanoma

MDSC

Immunometabolism

Cancer cell Metabolism

3D genome organization

Top articles of Bin Zheng

Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib

Cancer Research Communications

2023/12/4

Bin Zheng
Bin Zheng

H-Index: 23

Jonathan Zippin
Jonathan Zippin

H-Index: 17

Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

Iscience

2023/6/16

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

Nature metabolism

2022/12

Phenformin promotes keratinocyte differentiation via the calcineurin/NFAT pathway

Journal of Investigative Dermatology

2021/1/1

See List of Professors in Bin Zheng University(Harvard University)